Genetic Finding leads to new hypotheses for treatment of Central Serous Chorioretinopathy.
September 27, 2024Elizabeth Rossin https://www.sciencedirect.com/science/article/abs/pii/S0002939424004082?dgcid=author
OGI Clinician Scientists recognized for excellence in clinical care and research
July 23, 2024Rachel Huckfeldt MD, PhD is among the 2024 honorees for the Anne Klibanski Visiting Scholars Award. This award is presented to women faculty clinicians, educators, researchers, and postdoctoral fellows who have demonstrated exceptional promise as leaders in their... Read More
OGI investigators validate new technique to predict pathogenic variants associated with inherited retinal disease
June 11, 2024Advances in gene sequencing technologies have accelerated the identification of genetic variants, but better tools are needed to understand which are causal of disease. This would be particularly useful in fields where gene therapy is a potential therapeutic modality for a disease-causing variant such as inherited retinal disease (IRD). Read More
CRISPR Gene Editing shown to be effective in improving vision
May 20, 2024Boston, Mass. — Results from a groundbreaking clinical trial of CRISPR gene editing in 14 individuals with a form of inherited blindness show that the treatment is safe and led to measurable improvements in 11 of the participants treated. The phase 1/2 trial called BRILLIANCE, was led by principal investigator Read More
Knights Templar Eye Foundation 2024- 2025 Career Starter Grants
May 2, 2024Ocular Genomics Institute members Hanmeng Zhang, Egle Galdikatie-Braziene, and Kannan Manian were awarded support for their work. Hanmeng Zhang, PhD: Investigating the role... Read More
Dr. Ryoji Amamoto receives Child Health Research Grant Award from the Charles H. Hood foundation.
January 29, 2024Ryoji Amamoto, PhD, an Assistant Scientist in the Department of Ophthalmology, has been selectedto receive a Child Health Research Grant Award fromthe Charles H. Hood Foundation. These highly competitive awards provide $200,000 over two years to support scientific research and advance the careers of promising scientists at premier New... Read More
Inas Aboobakar, M.D – K23 clinician-scientist grant recipient.
January 29, 2024Dr. Inas Aboobakar of the Wiggs lab received a K23 clinician-scientist grant from the National Eye Institute. With this grant, Dr. Aboobakar will investigate the clinical impact and underlying disease mechanisms for glaucoma-associated genes that function in the mitochondria, the energy-producing parts of cells. This work is designed to help pave... Read More
Research to Prevent Blindness/The Glaucoma Foundation 2023 Career Advancement Award
January 29, 2024Ayellet Segrè, PhD, an Assistant Professor of Ophthalmology at Mass Eye and Ear, Harvard Medical School, received the Research to Prevent Blindness/The Glaucoma Foundation 2023 Career Advancement Award. Dr. Segrè will use this award to identify genetic regulatory effects at the single cell level in the aqueous humor outflow pathways, retina,... Read More
Shedding light on glaucoma causal mechanisms, genes and cell types
January 29, 2024Ayellet Segrè, PhD, an Assistant Professor of Ophthalmology at Harvard Medical School, and Genetic Biostatistician at the Ocular Genomics Institute at Mass. Eye and Ear (MEE), and her lab members, in collaboration with Janey Wiggs, MD, Ph.D., Ocular Genomics Institute Associate Director, and Professor of Ophthalmology at HMS, Josh Sanes,... Read More
Elizabeth Rossin – 2024 Glaser Award recipient
January 23, 2024The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates Elizabeth Rossin, MD, PhD — 2024 recipient of the Bert M. Glaser, MD Award for Innovative Research in Retina. The award recognizes an early-career investigator who has discovered a novel drug, technique, or the understanding of a mechanism of disease... Read More
Ayellet Segrè Receives RPB/Glaucoma Foundation Career Advancement Award
January 23, 2024Ayellet Segrè (Mass Eye and Ear) has been recognized with the Research to Prevent Blindness (RPB)/Glaucoma Foundation Career Advancement Award. Hundreds of common DNA variants have been found to be associated with primary open-angle glaucoma (POAG). The majority of these variants lie in noncoding regions and likely affect glaucoma through... Read More